These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31893239)

  • 1. IgG4 subclass and gamma-glutamyl transferase in children with ulcerative colitis with primary sclerosing cholangitis and without sclerosing cholangitis.
    Farahmand F; Ahmadi M; Khodadad A; Najafi M; Fallahi G; Motamed F; Movahedi M; Aghamohammadi A; Rezaei N; Javaherizadeh H
    Clin Exp Hepatol; 2019 Nov; 5(4):285-288. PubMed ID: 31893239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF.
    Fossdal G; Mjelle AB; Wiencke K; Bjørk I; Gilja OH; Folseraas T; Karlsen TH; Rosenberg W; Giil LM; Vesterhus M
    JHEP Rep; 2021 Oct; 3(5):100328. PubMed ID: 34485881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
    Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
    JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated immunoglobulin G4 level is associated with reduced colectomy-free survival in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Venkatesh PG; Choudhary M; Shen B; Kiran RP
    J Crohns Colitis; 2013 Mar; 7(2):e35-41. PubMed ID: 22554774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Utility of Personalized Serum IgG Subclass Ratios for the Differentiation of IgG4-Related Sclerosing Cholangitis (IgG4-SC) from Primary Sclerosing Cholangitis (PSC) and Cholangiocarcinoma (CCA).
    Park JK; Kim D; Lee JM; Lee KH; Lee KT; Park JK; Lee JK
    J Pers Med; 2022 May; 12(6):. PubMed ID: 35743640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?
    Nakazawa T; Naitoh I; Hayashi K; Sano H; Miyabe K; Shimizu S; Joh T
    World J Gastroenterol; 2014 Mar; 20(12):3245-54. PubMed ID: 24696608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of sclerosing cholangitis and the relevance of IgG4 elevations in routine practice.
    Alswat K; Al-Harthy N; Mazrani W; Alshumrani G; Jhaveri K; Hirschfield GM
    Am J Gastroenterol; 2012 Jan; 107(1):56-63. PubMed ID: 22068666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary sclerosing cholangitis with elevated serum IgG4 levels and/or infiltration of abundant IgG4-positive plasma cells.
    Koyabu M; Uchida K; Fukata N; Kusuda T; Ikeura T; Sakaguchi Y; Yoshida K; Shimatani M; Fukui T; Matsushita M; Uemura Y; Kaibori M; Takaoka M; Nishio A; Okazaki K
    J Gastroenterol; 2010; 45(1):122-9. PubMed ID: 19760481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass.
    Bansi DS; Fleming KA; Chapman RW
    Gut; 1996 Mar; 38(3):384-9. PubMed ID: 8675091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of primary sclerosing cholangitis with increased IgG4 levels.
    Manganis CD; Chapman RW; Culver EL
    World J Gastroenterol; 2020 Jun; 26(23):3126-3144. PubMed ID: 32684731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique Inflammatory Bowel Disease Phenotype of Pediatric Primary Sclerosing Cholangitis: A Single-Center Study.
    Shiau H; Ihekweazu FD; Amin M; Fofanova T; Miloh T; Kellermayer R
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):404-409. PubMed ID: 28141677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
    Radford-Smith DE; Selvaraj EA; Peters R; Orrell M; Bolon J; Anthony DC; Pavlides M; Lynch K; Geremia A; Bailey A; Culver EL; Probert F
    Liver Int; 2022 Jun; 42(6):1344-1354. PubMed ID: 35129255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Proteinase 3 Antibodies as a Biomarker for Ulcerative Colitis and Primary Sclerosing Cholangitis in Children.
    Laass MW; Ziesmann J; de Laffolie J; Röber N; Conrad K
    J Pediatr Gastroenterol Nutr; 2022 Apr; 74(4):463-470. PubMed ID: 35703948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geoepidemiology of primary sclerosing cholangitis: a critical review.
    Tanaka A; Takikawa H
    J Autoimmun; 2013 Oct; 46():35-40. PubMed ID: 23932346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcerative colitis with concomitant primary sclerosing cholangitis.
    Mohamed AK; Seow CE
    Med J Malaysia; 2020 Nov; 75(6):756-758. PubMed ID: 33219195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and clinical courses of concomitant primary sclerosing cholangitis and ulcerative colitis: a Korean multicenter study.
    Park YE; Cheon JH; Park JJ; Kim YJ; Choi CH; Park Y; Park SJ; Kim TI; Kim WH
    Int J Colorectal Dis; 2018 Oct; 33(10):1497-1500. PubMed ID: 29987360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of ulcerative colitis on liver-related outcomes of children with primary sclerosing cholangitis.
    Sathiaseelan M; Bolia R; Barallon R; Alex G; Hardikar W; Rajanayagam J
    J Paediatr Child Health; 2022 Jul; 58(7):1221-1227. PubMed ID: 35373867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary sclerosing cholangitis with moderately elevated serum-IgG4 - characterization and outcome of a distinct variant phenotype.
    Zhou T; Lenzen H; Dold L; Bündgens B; Wedemeyer H; Manns MP; Gonzalez-Carmona MA; Strassburg CP; Weismüller TJ
    Liver Int; 2021 Dec; 41(12):2924-2933. PubMed ID: 34328259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan.
    Tanaka A; Tazuma S; Okazaki K; Tsubouchi H; Inui K; Takikawa H
    J Hepatobiliary Pancreat Sci; 2014 Jan; 21(1):43-50. PubMed ID: 24353071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Del Chierico F; Cardile S; Baldelli V; Alterio T; Reddel S; Bramuzzo M; Knafelz D; Lega S; Bracci F; Torre G; Maggiore G; Putignani L
    Inflamm Bowel Dis; 2024 Apr; 30(4):529-537. PubMed ID: 37696680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.